{"count": 5, "results": [{"_id": "39893002", "pmid": 39893002, "title": "Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer.", "journal": "J Pharmacol Exp Ther", "authors": ["Simpson K", "Allison DB", "He D", "Liu J", "Wang C", "Liu X"], "date": "2025-01-01T00:00:00Z", "doi": "10.1124/jpet.124.002424", "meta_date_publication": "2025 Jan", "meta_volume": "392", "meta_issue": "1", "meta_pages": "100034", "score": 50248.69, "text_hl": "After combination treatment, we observed a decrease in cell proliferation and viability as well as a synergistic effect of both @CHEMICAL_enzalutamide @CHEMICAL_MESH:C540278 @@@enzalutamide@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in vitro. Following these results, we sought to explore how combination treatment affected mitochondrial fitness using mitochondrial stress test analysis and mitochondrial membrane potential shifts due to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s action in inhibiting complex @<m>DISEASE_Hypersensitivity_Immediate</m> @DISEASE_MESH:D006969 @@@I of@@@ oxidative phosphorylation. ", "citations": {"NLM": "Simpson K, Allison DB, He D, Liu J, Wang C, Liu X. Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer. J Pharmacol Exp Ther. 2025 Jan;392(1):100034. PMID: 39893002", "BibTeX": "@article{39893002, title={Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer.}, author={Simpson K and Allison DB and He D and Liu J and Wang C and Liu X}, journal={J Pharmacol Exp Ther}, volume={392}, number={1}, pages={100034}}"}}, {"_id": "37623854", "pmid": 37623854, "pmcid": "PMC10456943", "title": "Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts", "journal": "Metabolites", "authors": ["Catalano L", "Aminzadeh-Gohari S", "Weber DD", "Poupardin R", "Stefan VE", "Smiles WJ", "Tevini J", "Feichtinger RG", "Derdak S", "Bilban M", "Bareswill S", "Heimesaat MM", "Kofler B"], "date": "2023-08-03T00:00:00Z", "doi": "10.3390/metabo13080910", "meta_date_publication": "2023 Aug 3", "meta_volume": "13", "meta_issue": "8", "meta_pages": "", "score": 50241.26, "text_hl": "The anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@MET@@@) also targets complex I of the OXPHOS system. ", "citations": {"NLM": "Catalano L, Aminzadeh-Gohari S, Weber DD, Poupardin R, Stefan VE, Smiles WJ, Tevini J, Feichtinger RG, Derdak S, Bilban M, Bareswill S, Heimesaat MM, Kofler B. Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts Metabolites. 2023 Aug 3;13(8):. PMID: 37623854", "BibTeX": "@article{37623854, title={Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts}, author={Catalano L and Aminzadeh-Gohari S and Weber DD and Poupardin R and Stefan VE and Smiles WJ and Tevini J and Feichtinger RG and Derdak S and Bilban M and Bareswill S and Heimesaat MM and Kofler B}, journal={Metabolites}, volume={13}, number={8}}"}}, {"_id": "4046836", "pmid": 4046836, "title": "Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients.", "journal": "Metabolism", "authors": ["Gin H", "Messerchmitt C", "Brottier E", "Aubertin J"], "date": "1985-10-01T00:00:00Z", "doi": "10.1016/0026-0495(85)90139-8", "meta_date_publication": "1985 Oct", "meta_volume": "34", "meta_issue": "10", "meta_pages": "923-5", "score": 50062.87, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improved @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ in @<m>DISEASE_Hypersensitivity_Immediate</m> @DISEASE_MESH:D006969 @@@type I, insulin@@@-dependent, @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Gin H, Messerchmitt C, Brottier E, Aubertin J. Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients. Metabolism. 1985 Oct;34(10):923-5. PMID: 4046836", "BibTeX": "@article{4046836, title={Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients.}, author={Gin H and Messerchmitt C and Brottier E and Aubertin J}, journal={Metabolism}, volume={34}, number={10}, pages={923-5}}"}}, {"_id": "23620761", "pmid": 23620761, "pmcid": "PMC3631250", "title": "Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners", "journal": "PLoS One", "authors": ["Sarfstein R", "Friedman Y", "Attias-Geva Z", "Fishman A", "Bruchim I", "Werner H"], "date": "2013-04-19T00:00:00Z", "doi": "10.1371/journal.pone.0061537", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "4", "meta_pages": "e61537", "score": 50042.906, "text_hl": "Recently, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was shown to exhibit anti-proliferative effects in @<m>DISEASE_Hypersensitivity_Immediate</m> @DISEASE_MESH:D006969 @@@ovarian and Type I endometrial cancer@@@, although the mechanisms responsible for this non-classical @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ action remain unclear. ", "citations": {"NLM": "Sarfstein R, Friedman Y, Attias-Geva Z, Fishman A, Bruchim I, Werner H. Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners PLoS One. 2013;8(4):e61537. PMID: 23620761", "BibTeX": "@article{23620761, title={Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners}, author={Sarfstein R and Friedman Y and Attias-Geva Z and Fishman A and Bruchim I and Werner H}, journal={PLoS One}, volume={8}, number={4}, pages={e61537}}"}}, {"_id": "26202922", "pmid": 26202922, "title": "Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.", "journal": "Hum Reprod", "authors": ["Kuang H", "Jin S", "Hansen KR", "Diamond MP", "Coutifaris C", "Casson P", "Christman G", "Alvero R", "Huang H", "Bates GW", "Usadi R", "Lucidi S", "Baker V", "Santoro N", "Eisenberg E", "Legro RS", "Zhang H", "Reproductive Medicine Network"], "date": "2015-09-01T00:00:00Z", "doi": "10.1093/humrep/dev182", "meta_date_publication": "2015 Sep", "meta_volume": "30", "meta_issue": "9", "meta_pages": "2222-33", "score": 50028.7, "text_hl": "Both trials were double-blind, randomized clinical trials that included 626 and 750 infertile @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, respectively. @<m>DISEASE_Hypersensitivity_Immediate</m> @DISEASE_MESH:D006969 @@@PPCOS-I@@@ participants were randomized to either @CHEMICAL_Clomiphene @CHEMICAL_MESH:D002996 @@@clomiphene citrate@@@ (CC), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, or their combination, and @DISEASE_Oculocutaneous_albinism_type_2 @DISEASE_MESH:C537730 @@@PPCOS-II@@@ participants to either @CHEMICAL_Letrozole @CHEMICAL_MESH:D000077289 @@@letrozole@@@ or CC for up to five treatment cycles. ", "citations": {"NLM": "Kuang H, Jin S, Hansen KR, Diamond MP, Coutifaris C, Casson P, Christman G, Alvero R, Huang H, Bates GW, Usadi R, Lucidi S, Baker V, Santoro N, Eisenberg E, Legro RS, Zhang H, Reproductive Medicine Network. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome. Hum Reprod. 2015 Sep;30(9):2222-33. PMID: 26202922", "BibTeX": "@article{26202922, title={Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.}, author={Kuang H and Jin S and Hansen KR and Diamond MP and Coutifaris C and Casson P and Christman G and Alvero R and Huang H and Bates GW and Usadi R and Lucidi S and Baker V and Santoro N and Eisenberg E and Legro RS and Zhang H and Reproductive Medicine Network}, journal={Hum Reprod}, volume={30}, number={9}, pages={2222-33}}"}}]}